High prevalence of dysfibrinogenemia among patients with chronic thromboembolic pulmonary hypertension

The mechanism by which chronic thromboembolic pulmonary hypertension (CTEPH) develops after acute pulmonary thromboembolism is unknown. We previously reported that fibrin from CTEPH patients is relatively resistant to fibrinolysis in vitro. In the present study, we performed proteomic, genomic, and...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Morris, Timothy A., Marsh, James J., Chiles, Peter G., Magaña, Marisa M., Liang, Ni-Cheng, Soler, Xavier, DeSantis, Daniel J., Ngo, Debby, Woods, Virgil L.
Format: Artigo
Jezik:Inglês
Izdano: American Society of Hematology 2009
Teme:
Thrombosis and Hemostasis
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2738577/
https://ncbi.nlm.nih.gov/pubmed/19420351
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2009-03-208264
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items